Global Reach

Asia Pacific

Over the past decade we have been active in advising clients in mergers and acquisitions, joint ventures, private equity and venture capital investments, capital markets, IP, and litigation and investigations work. Willkie’s team of lawyers has relationships with local firms to help international clients seeking opportunities in Asia, as well as companies in Japan, China, India, Thailand, South Korea, Indonesia and Malaysia pursuing global business prospects.

Featured Asia Pacific Experience

Fortress Investment Group to Be Acquired by SoftBank Group
Willkie represented Morgan Stanley as financial advisor to Fortress Investment Group in its $3.3 billion acquisition by Japan-based SoftBank Group.

Genworth Financial in $2.7 Billion Pending Acquisition by China Oceanwide
Willkie represented Genworth Financial in its $2.7 billion pending acquisition by China Oceanwide; the transaction includes an additional $1.1 billion capital contribution.

AssetMark to Be Acquired by Huatai Securities
Willkie represented AssetMark, Inc. in its purchase by Huatai Securities from Aquiline Capital Partners and Genstar Capital.

WuXi PharmaTech Enters Into $3.3 Billion LBO
Willkie represented the Special Committee of the Board of Directors of WuXi PharmaTech Inc. in its $3.3 billion management-led leveraged buyout, one of the largest going private transactions of a Chinese-based, U.S. listed company.

Dai-ichi Life in $5.7 Billion Acquisition of Protective Life
Willkie represented Tokyo-based Dai-ichi Life Insurance Company, Limited in its $5.7 billion acquisition of Protective Life Corporation. Dai-ichi Life, the second largest private life insurance company in Japan, is one of the top 20 global life insurers, operating  throughout Japan, Australia, Vietnam, Indonesia, India and Thailand.

Cornerstone Investor in Largest-Ever IPO in Thailand
Willkie advised a cornerstone investor in BTS Group Holdings PCL's $2.13 billion initial public offering, the largest-ever IPO in Thailand.

Sepracor in $2.6 Billion Acquisition by Dainippon Sumitomo Pharma
Japanese pharmaceutical manufacturer Dainippon Sumitomo Pharma Co., Ltd. (DSP) acquired Willkie client Sepracor Inc., a specialty drug maker, for approximately $2.6 billion.

iParadigms in $752 Million Sale
GIC, Singapore's sovereign wealth fund, and Insight Venture partners agreed to acquire Willkie client iParadigms, a California-based anti-plagiarism software company, from majority owner Warburg Pincus.

Ticket Monster, Inc.
Willkie represented Ticket Monster, South Korea’s top social commerce site, in its sale to U.S.-based LivingSocial. (2011)